JP2020502111A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502111A5 JP2020502111A5 JP2019531649A JP2019531649A JP2020502111A5 JP 2020502111 A5 JP2020502111 A5 JP 2020502111A5 JP 2019531649 A JP2019531649 A JP 2019531649A JP 2019531649 A JP2019531649 A JP 2019531649A JP 2020502111 A5 JP2020502111 A5 JP 2020502111A5
- Authority
- JP
- Japan
- Prior art keywords
- oxy
- hydrogen
- indene
- hex
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2016-0171541 | 2016-12-15 | ||
| KR20160171541 | 2016-12-15 | ||
| KR1020170171228A KR102007633B1 (ko) | 2016-12-15 | 2017-12-13 | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| KR10-2017-0171228 | 2017-12-13 | ||
| PCT/KR2017/014757 WO2018111012A1 (en) | 2016-12-15 | 2017-12-14 | Novel phenyl propionic acid derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502111A JP2020502111A (ja) | 2020-01-23 |
| JP2020502111A5 true JP2020502111A5 (https=) | 2020-11-12 |
| JP6892922B2 JP6892922B2 (ja) | 2021-06-23 |
Family
ID=62559593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531649A Expired - Fee Related JP6892922B2 (ja) | 2016-12-15 | 2017-12-14 | 新規フェニルプロピオン酸誘導体及びその用途 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11225472B2 (https=) |
| EP (1) | EP3555076B1 (https=) |
| JP (1) | JP6892922B2 (https=) |
| KR (1) | KR102007633B1 (https=) |
| CN (1) | CN110049984B (https=) |
| AU (1) | AU2017374460B2 (https=) |
| BR (1) | BR112019012433A2 (https=) |
| CA (1) | CA3042528C (https=) |
| DK (1) | DK3555076T3 (https=) |
| ES (1) | ES2948485T3 (https=) |
| FI (1) | FI3555076T3 (https=) |
| HU (1) | HUE062468T2 (https=) |
| IL (1) | IL267239B (https=) |
| MX (1) | MX2019007071A (https=) |
| MY (1) | MY198292A (https=) |
| PH (1) | PH12019501251A1 (https=) |
| PL (1) | PL3555076T3 (https=) |
| PT (1) | PT3555076T (https=) |
| RS (1) | RS64259B1 (https=) |
| RU (1) | RU2760266C2 (https=) |
| SI (1) | SI3555076T1 (https=) |
| WO (1) | WO2018111012A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220112185A1 (en) * | 2016-12-15 | 2022-04-14 | Ildong Pharmaceutical Co., Ltd. | Novel phenyl propionic acid derivatives and uses thereof |
| KR102007633B1 (ko) * | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| BR102018007822A2 (pt) | 2017-04-20 | 2018-11-06 | Gilead Sciences, Inc. | composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição |
| TWI707849B (zh) | 2018-02-13 | 2020-10-21 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
| US12083118B2 (en) | 2018-03-29 | 2024-09-10 | Arbutus Biopharma Corporation | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same |
| KR102591947B1 (ko) | 2018-04-19 | 2023-10-25 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| EP3820572B1 (en) | 2018-07-13 | 2023-08-16 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| US11236085B2 (en) | 2018-10-24 | 2022-02-01 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ，インク． | Ｇｐｒ１１９アゴニスト |
| IL295825A (en) | 2020-02-28 | 2022-10-01 | Kallyope Inc | gpr40 agonists |
| WO2021236617A1 (en) | 2020-05-19 | 2021-11-25 | Kallyope, Inc. | Ampk activators |
| CA3183575A1 (en) | 2020-06-26 | 2021-12-30 | Iyassu Sebhat | Ampk activators |
| BR112023022114A2 (pt) * | 2021-04-29 | 2024-01-30 | Ildong Pharmaceutical Co Ltd | Composto farmacêutico compreendendo agonista de gpr40 e inibidor de sglt-2 |
| WO2022269439A1 (en) * | 2021-06-21 | 2022-12-29 | Ildong Pharmaceutical Co., Ltd. | Method of controlling blood sugar level and treatment of diabetes and related conditions |
| WO2023080299A1 (ko) * | 2021-11-08 | 2023-05-11 | 일동제약(주) | 페닐 프로피온 산 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR20240084229A (ko) * | 2022-12-06 | 2024-06-13 | 유노비아 주식회사 | 안정성이 향상된 gpr40 효현제를 유효성분으로 포함하는 약제학적 조성물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4594611B2 (ja) * | 2002-11-08 | 2010-12-08 | 武田薬品工業株式会社 | 受容体機能調節剤 |
| JP5299810B2 (ja) * | 2004-02-27 | 2013-09-25 | アムジエン・インコーポレーテツド | 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法 |
| US7786165B2 (en) * | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
| CA2620476A1 (en) * | 2005-06-02 | 2006-12-07 | Jenrin Discovery | Mao-b inhibitors useful for treating obesity |
| WO2007033002A1 (en) * | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| JP5055852B2 (ja) | 2006-06-21 | 2012-10-24 | 住友大阪セメント株式会社 | 鉄資源の回収方法 |
| AR084050A1 (es) * | 2010-12-01 | 2013-04-17 | Boehringer Ingelheim Int | Acidos indaniloxidihidrobenzofuranilaceticos |
| JP2013147443A (ja) * | 2012-01-18 | 2013-08-01 | Daiichi Sankyo Co Ltd | β置換カルボン酸誘導体 |
| US8633182B2 (en) * | 2012-05-30 | 2014-01-21 | Boehringer Ingelheim International Gmbh | Indanyloxyphenylcyclopropanecarboxylic acids |
| WO2015044073A1 (en) * | 2013-09-26 | 2015-04-02 | Boehringer Ingelheim International Gmbh | Process and intermediates for preparing indanyloxydihydrobenzofuranyl acetic acid derivatives as gpr40 agonists |
| WO2017180457A1 (en) | 2016-04-11 | 2017-10-19 | Janssen Pharmaceutica Nv | Gpr40 agonists in anti-diabetic drug combinations |
| KR102007633B1 (ko) * | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| US20220112185A1 (en) * | 2016-12-15 | 2022-04-14 | Ildong Pharmaceutical Co., Ltd. | Novel phenyl propionic acid derivatives and uses thereof |
| BR112023022114A2 (pt) * | 2021-04-29 | 2024-01-30 | Ildong Pharmaceutical Co Ltd | Composto farmacêutico compreendendo agonista de gpr40 e inibidor de sglt-2 |
| WO2022269439A1 (en) * | 2021-06-21 | 2022-12-29 | Ildong Pharmaceutical Co., Ltd. | Method of controlling blood sugar level and treatment of diabetes and related conditions |
| US20230022803A1 (en) * | 2021-06-25 | 2023-01-26 | Ildong Pharmaceutical Co., Ltd. | Novel crystalline form of gpr40 agonist |
-
2017
- 2017-12-13 KR KR1020170171228A patent/KR102007633B1/ko active Active
- 2017-12-14 WO PCT/KR2017/014757 patent/WO2018111012A1/en not_active Ceased
- 2017-12-14 EP EP17880872.1A patent/EP3555076B1/en active Active
- 2017-12-14 JP JP2019531649A patent/JP6892922B2/ja not_active Expired - Fee Related
- 2017-12-14 PL PL17880872.1T patent/PL3555076T3/pl unknown
- 2017-12-14 CN CN201780074801.4A patent/CN110049984B/zh not_active Expired - Fee Related
- 2017-12-14 HU HUE17880872A patent/HUE062468T2/hu unknown
- 2017-12-14 PT PT178808721T patent/PT3555076T/pt unknown
- 2017-12-14 CA CA3042528A patent/CA3042528C/en active Active
- 2017-12-14 BR BR112019012433A patent/BR112019012433A2/pt not_active Application Discontinuation
- 2017-12-14 US US16/467,654 patent/US11225472B2/en not_active Expired - Fee Related
- 2017-12-14 IL IL267239A patent/IL267239B/en unknown
- 2017-12-14 MX MX2019007071A patent/MX2019007071A/es unknown
- 2017-12-14 MY MYPI2019003388A patent/MY198292A/en unknown
- 2017-12-14 FI FIEP17880872.1T patent/FI3555076T3/fi active
- 2017-12-14 ES ES17880872T patent/ES2948485T3/es active Active
- 2017-12-14 RU RU2019121871A patent/RU2760266C2/ru active
- 2017-12-14 AU AU2017374460A patent/AU2017374460B2/en not_active Ceased
- 2017-12-14 RS RS20230456A patent/RS64259B1/sr unknown
- 2017-12-14 SI SI201731367T patent/SI3555076T1/sl unknown
- 2017-12-14 DK DK17880872.1T patent/DK3555076T3/da active
-
2019
- 2019-06-06 PH PH12019501251A patent/PH12019501251A1/en unknown
-
2021
- 2021-11-10 US US17/523,652 patent/US11731961B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502111A5 (https=) | ||
| RU2019121871A (ru) | Новые производные фенилпропионовой кислоты и их применение | |
| JP2007523155A5 (https=) | ||
| JP2017511329A5 (https=) | ||
| JP2012506381A5 (https=) | ||
| JP2016535000A5 (https=) | ||
| JP2018534355A5 (https=) | ||
| JP2011502958A5 (https=) | ||
| JP2018535967A5 (https=) | ||
| JP2016526540A5 (https=) | ||
| JP2009534386A5 (https=) | ||
| JP2003528095A5 (https=) | ||
| JP2019505595A5 (https=) | ||
| JP2018534288A5 (https=) | ||
| RU2016102313A (ru) | Биарильные производные в качестве агонистов gpr120 | |
| JP2020527175A5 (https=) | ||
| JP2014523400A5 (https=) | ||
| RU2015100942A (ru) | Производное пиперидинилпиразолпиридина | |
| JP2015519322A5 (https=) | ||
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| JP2017536342A5 (https=) | ||
| JP2020503293A5 (https=) | ||
| JP2004524279A5 (https=) | ||
| JP2020500192A5 (https=) | ||
| JP2006516626A5 (https=) |